Chemoembolization of Hepatocellular Carcinoma [PDF]
Seminars in Interventional Radiology, 2013 Transarterial chemoembolization (TACE) is the current standard of care for patients with intermediate-stage hepatocellular carcinoma (HCC) and relatively preserved liver function. In a meta-analysis of randomized controlled trials comparing conventional TACE regimens-including the administration of an anticancer-in-oil emulsion followed by embolic ...
Riccardo Antonio Lencioni +2 more
exaly +4 more sources
A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma [PDF]
ESMO Gastrointestinal OncologyBackground: Drug-eluting bead transarterial chemoembolization (deb-TACE) is a standard for liver-limited, locally advanced hepatocellular carcinoma (HCC) and may enhance response to immune checkpoint inhibition through tumor immune microenvironment ...
J.J. Harding +22 more
doaj +2 more sources
THE BASICS OF CHEMOEMBOLIZATION
RUDN Journal of Medicine, 2017 Chemoembolization has advantages over systemic chemotherapy as increase in drug concentration, time of exposition and decrease in systemic adverse effects.
D G Gitelson +3 more
openaire +3 more sources
Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study [PDF]
Frontiers in ImmunologyObjectivesThis study aimed to investigate the efficacy and safety of transarterial chemoembolization (TACE) plus sintilimab and bevacizumab biosimilar as first-line therapy for intermediate-advanced hepatocellular carcinoma (HCC).Materials and methodsA ...
Li-Wei Deng +18 more
doaj +2 more sources
X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy [PDF]
Клиническая практика, 2022 Background: At present, the problem of treating common forms of colorectal cancer does not lose its relevance due to the increase in its incidence.
Oksana Yu. Stukalova +3 more
doaj +1 more source
Current Oncology, 2021 Chemoembolization with irinotecan-loaded microspheres has proven effective in the treatment of unresectable liver metastases in the course of colorectal cancer (CRC).
Marcin Szemitko +3 more
doaj +1 more source
Journal of Clinical Interventional Radiology ISVIR, 2020 Aim To evaluate whether right inferior phrenic artery (RIPA) is a source of extrahepatic arterial supply to the liver in cirrhotic patients without hepatocellular carcinoma (HCC) using 256 slice computed tomography (CT).
Chinmay Bhimaji Kulkarni +4 more
doaj +1 more source
Medicina, 2023 Background and Objectives: This study aimed to evaluate the added value of cone-beam computed tomography (CBCT) for detecting hepatocellular carcinomas (HCC) and feeding arteries during transcatheter arterial chemoembolization (TACE).
Duk-Ju Kim +8 more
doaj +1 more source
Real-Time Prediction of Transarterial Drug Delivery Based on a Deep Convolutional Neural Network
Applied Sciences, 2022 This study develops a data-driven reduced-order model based on a deep convolutional neural network (CNN) for real-time and accurate prediction of the drug trajectory and concentration field in transarterial chemoembolization therapy to assist in ...
Xin-Yi Yuan +6 more
doaj +1 more source
Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association [PDF]
Journal of Liver Cancer, 2023 Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established as conventional ...
Yuri Cho +13 more
doaj +1 more source